Association between NADPH Oxidase p22phox C242T Polymorphism and Ischemic Cerebrovascular Disease: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Li, Bing Hu ^a   Zhang, Li Li ^a   Zhang, Bei Bei ^b   Yin, Yan Wei ^a   Dai, Li Meng ^c   Pi, Yan ^a   Guo, Lu ^a   Gao, Chang Yue ^a   Fang, Chuan Qin ^a   Wang, Jing Zhou ^a   Li, Jing Cheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b General Hospital of PLA Chengdu Military Area Command   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P22 PHOX; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; ATHEROSCLEROSIS; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; GENETIC POLYMORPHISM; HUMAN; ISCHEMIC CEREBROVASCULAR DISEASE; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

BRAIN ISCHEMIA; HUMANS; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84873654722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056478     Document Type: Article

References (54)

1. Frey RS, Ushio-Fukai M, Malik AB, (2009) NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal 11: 791-810.
2. Custodis F, Baumhakel M, Schlimmer N, List F, Gensch C, et al. (2008) Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 117: 2377-2387.
3. Chan PH, (1996) Role of oxidants in ischemic brain damage. Stroke 27: 1124-1129.
4. He YY, Hsu CY, Ezrin AM, Miller MS, (1993) Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion. Am J Physiol 265: H252-256.
5. Imaizumi S, Woolworth V, Fishman RA, Chan PH, (1990) Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 21: 1312-1317.
6. Madamanchi NR, Vendrov A, Runge MS, (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25: 29-38.
7. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY, (1989) Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 256: H589-593.
8. Bedard K, Krause KH, (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313.
9. DeLeo FR, Renee J, McCormick S, Nakamura M, Apicella M, et al. (1998) Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest 101: 455-463.
10. Griendling KK, (2004) Novel NAD(P)H oxidases in the cardiovascular system. Heart 90: 491-493.
11. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK, (1996) p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321.
12. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, et al. (2002) Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91: 1160-1167.
13. Lassegue B, Clempus RE, (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-297.
14. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, Orkin SH, (1990) Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86: 1729-1737.
15. Zafari AM, Davidoff MN, Austin H, Valppu L, Cotsonis G, et al. (2002) The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease. Antioxid Redox Signal 4: 675-680.
16. Moreno MU, San Jose G, Orbe J, Paramo JA, Beloqui O, et al. (2003) Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension. FEBS Lett 542: 27-31.
17. Moreno MU, San Jose G, Fortuno A, Beloqui O, Redon J, et al. (2007) A novel CYBA variant, the-675A/T polymorphism, is associated with essential hypertension. J Hypertens 25: 1620-1626.
18. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, et al. (2000) Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102: 1744-1747.
19. Perianayagam MC, Liangos O, Kolyada AY, Wald R, MacKinnon RW, et al. (2007) NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 18: 255-263.
20. Moreno MU, San Jose G, Fortuno A, Beloqui O, Diez J, et al. (2006) The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens 24: 1299-1306.
21. Lim SC, Goh SK, Lai YR, Tee WW, Koh A, et al. (2006) Relationship between common functional polymorphisms of the p22phox gene (-930A>G and +242C>T) and nephropathy as a result of Type 2 diabetes in a Chinese population. Diabet Med 23: 1037-1041.
22. Shimokata K, Yamada Y, Kondo T, Ichihara S, Izawa H, et al. (2004) Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis 172: 167-173.
23. Nasti S, Spallarossa P, Altieri P, Garibaldi S, Fabbi P, et al. (2006) C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians. Dis Markers 22: 167-173.
24. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, et al. (2000) C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 31: 936-939.
25. Krex D, Ziegler A, Konig IR, Schackert HK, Schackert G, (2003) Polymorphisms of the NADPH oxidase P22PHOX gene in a Caucasian population with intracranial aneurysms. Cerebrovasc Dis 16: 363-368.
26. Kuroda J, Kitazono T, Ago T, Ninomiya T, Ooboshi H, et al. (2007) NAD(P)H oxidase p22phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama study. Eur J Neurol 14: 1091-1097.
27. Genius J, Grau AJ, Lichy C, (2008) The C242T polymorphism of the NAD(P)H oxidase p22phox subunit is associated with an enhanced risk for cerebrovascular disease at a young age. Cerebrovasc Dis 26: 430-433.
28. Shimo-Nakanishi Y, Hasebe T, Suzuki A, Mochizuki H, Nomiyama T, et al. (2004) Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 175: 109-115.
29. Khan U, Bevan S, Markus HS, (2007) NADPH oxidase polymorphisms in cerebral small vessel disease. Cerebrovasc Dis 24: 135-138.
30. Niemiec P, Zak I, Emich-Widera E, Balcerzyk A, Kopyta I, et al. (2010) The C242T polymorphism of the gene encoding cytochrome b-245 alpha is not associated with paediatric ischaemic stroke: family-based and case-control study. Neurol Neurochir Pol 44: 453-458.
31. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
32. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
33. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
34. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P, (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 2011 Dec 1.
35. Lewis CM, (2002) Genetic association studies: design, analysis and interpretation. Brief Bioinform 3: 146-153.
36. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
37. Higgins JPTS, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
38. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
39. Fischer-Rosinsky A, Fisher E, Kovacs P, Bluher M, Mohlig M, et al. (2008) Lack of association between the tagging SNP A+930→G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations. PLoS One 3: e3852.
40. San Jose G, Fortuno A, Beloqui O, Diez J, Zalba G, (2008) NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci (Lond) 114: 173-182.
41. Huang XS, Yang QD, Long XY, Liu YH, Liu HF, et al. (2007) [The relationship of P47phox C923T (Ala308Val) polymorphism to cerebral infarction and its effect on plasma lipid levels]. Zhonghua Yi Xue Za Zhi 87: 2062-2064.
42. Huang XS, Yang QD, Guo TS, Long XY, Yang J, et al. (2007) [The relationship between the exon 10 of the p47(phox) polymorphism and stroke and the effect of the polymorphism on plasma lipid]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24: 524-528.
43. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. (2010) Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: 948-954.
44. Donnan GA, Fisher M, Macleod M, Davis SM, (2008) Stroke. Lancet 371: 1612-1623.
45. Dahabreh IJ, Kitsios GD, Kent DM, Trikalinos TA, (2010) Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis. Genet Med 12: 606-615.
46. Xu X, Li X, Li J, Ou R, Sheng W, (2010) Meta-analysis of association between variation in the PDE4D gene and ischemic cerebral infarction risk in Asian populations. Neurogenetics 11: 327-333.
47. Shi TY, He J, Qiu LX, Zhu ML, Wang MY, et al. (2012) Association between XPF Polymorphisms and Cancer Risk: A Meta-Analysis. PLoS One 7: e38606.
48. Edmondson D, Richardson S, Falzon L, Davidson KW, Mills MA, et al. (2012) Posttraumatic Stress Disorder Prevalence and Risk of Recurrence in Acute Coronary Syndrome Patients: A Meta-analytic Review. PLoS One 7: e38915.
49. Gorlach A, Brandes RP, Bassus S, Kronemann N, Kirchmaier CM, et al. (2000) Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J 14: 1518-1528.
50. Corsetti JP, Ryan D, Moss AJ, Zareba W, Sparks CE, (2008) NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients. Atherosclerosis 196: 461-468.
51. Harrison R, (2004) Physiological roles of xanthine oxidoreductase. Drug Metab Rev 36: 363-375.
52. Schulz UG, Flossmann E, Rothwell PM, (2004) Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 35: 819-824.
53. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS, (2003) Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 34: 1364-1369.
54. International HapMap Project (2012) Available: http://hapmapncbinlmnihgov. Accessed 2012 Nov 28.